Entropy Neurodynamics Limited (ASX:ENP)
Australia
· Delayed Price · Currency is AUD 0.0380
+0.0010 (2.70%)
Apr 29, 2026, 3:51 PM AEST
Entropy Neurodynamics Revenue
Entropy Neurodynamics had revenue of 1.58M AUD in the twelve months ending December 31, 2025. In the fiscal year ending June 30, 2025, Entropy Neurodynamics had annual revenue of 1.58M with 19.17% growth.
Revenue
1.58M
Revenue Growth
+19.17%
P/S Ratio
39.20
Revenue / Employee
n/a
Employees
n/a
Market Cap
62.01M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Prescient Therapeutics | 4.27M |
| Neurizon Therapeutics | 5.98M |
| Imugene | 3.94M |
| Proteomics International Laboratories | 3.21M |
| LTR Pharma | 1.13M |
| Avecho Biotechnology | 1.24M |
| Radiopharm Theranostics | 16.28M |
| NeuroScientific Biopharmaceuticals | 317.91K |